Ivana Magovcevic-Liebisch

Insider Reports History

Entity
Individual
Location
300 Technology Square, 8 Th Floor, Cambridge, MA
Signature
/s/ Michael Cohen, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ivana Magovcevic-Liebisch:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Vigil Neuroscience, Inc. President and CEO, Director Stock Option Award (Right to Buy) 370K $2.82M $7.62 May 3, 2024 Direct
Vigil Neuroscience, Inc. President and CEO, Director Common Stock 223K $374K $1.68 Dec 19, 2024 Direct
Quanterix Corp Director Common Stock 12.8K $160K $12.50 Oct 2, 2024 Direct
Aeglea BioTherapeutics, Inc. Director Stock Option (right to buy) 1.95M Jun 22, 2023 Direct
Vigil Neuroscience, Inc. President and CEO, Director Stock Option Grant (Right to Buy) 463K Mar 1, 2024 Direct
Acrivon Therapeutics, Inc. Director Stock Option (Right to Buy) 32.5K Feb 8, 2024 Direct
Absci Corp Director Stock Option (right to buy) 28.7K Jun 8, 2022 Direct
APPLIED GENETIC TECHNOLOGIES CORP Director Stock Option (right to buy) 14K Nov 30, 2021 Direct

Insider Reports Filed by Ivana Magovcevic-Liebisch

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VIGL Vigil Neuroscience, Inc. Dec 19, 2024 1 $8.4K 4 Dec 19, 2024 President and CEO, Director
VIGL Vigil Neuroscience, Inc. Dec 18, 2024 1 $8.35K 4 Dec 18, 2024 President and CEO, Director
VIGL Vigil Neuroscience, Inc. Dec 5, 2024 1 $11.7K 4 Dec 5, 2024 President and CEO, Director
QTRX Quanterix Corp Oct 2, 2024 2 $0 4 Oct 3, 2024 Director
QTRX Quanterix Corp Oct 2, 2024 0 $0 3 Oct 3, 2024 Director
VIGL Vigil Neuroscience, Inc. May 3, 2024 4 $0 4 May 7, 2024 President and CEO, Director
VIGL Vigil Neuroscience, Inc. Mar 1, 2024 1 $0 4 Mar 1, 2024 President and CEO, Director
ACRV Acrivon Therapeutics, Inc. Feb 8, 2024 1 $0 4 Feb 9, 2024 Director
ACRV Acrivon Therapeutics, Inc. Feb 8, 2024 0 $0 3 Feb 9, 2024 Director
VIGL Vigil Neuroscience, Inc. Nov 20, 2023 1 $15K 4 Nov 20, 2023 President and CEO, Director
AGLE Aeglea BioTherapeutics, Inc. Jun 22, 2023 1 $0 4 Jun 30, 2023 Director
VIGL Vigil Neuroscience, Inc. Mar 1, 2023 1 $0 4 Mar 3, 2023 President and CEO, Director
ABSI Absci Corp Jun 8, 2022 1 $0 4 Jun 10, 2022 Director
AGLE Aeglea BioTherapeutics, Inc. Jun 7, 2022 1 $0 4 Jun 9, 2022 Director
VIGL Vigil Neuroscience, Inc. May 2, 2022 2 $18.4K 4 May 4, 2022 President and CEO, Director
VIGL Vigil Neuroscience, Inc. Mar 1, 2022 1 $0 4 Mar 3, 2022 President and CEO, Director
VIGL Vigil Neuroscience, Inc. Jan 6, 2022 0 $0 3 Jan 6, 2022 President and CEO, Director
AGTC APPLIED GENETIC TECHNOLOGIES CORP Nov 30, 2021 1 $0 4 Dec 2, 2021 Director
ABSI Absci Corp Jul 21, 2021 0 $0 3 Jul 21, 2021 Director
AGLE Aeglea BioTherapeutics, Inc. Jun 8, 2021 1 $0 4 Jun 9, 2021 Director